Jin Medical International ratios data for the quarter ended Mar 2026. These financial ratios cover 7 quarters of results from Mar 2023 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Mar2023 | Sep2023 | Mar2024 | Sep2024 | Mar2025 | Sep2025 | Mar2026 |
|---|---|---|---|---|---|---|---|
| Efficiency | |||||||
| Inventory AverageInventory Avg. | 3,362.21B | 2,526.57B | 4,796.99B | 4,857.15B | 4,814.26B | 2,227.53B | 0.01B |
| Assets AverageAssets Avg. | 0.03B | 0.03B | 0.04B | 0.04B | 0.05B | 0.05B | 0.05B |
| Invested CapitalInvested Cap. | 0.03B | 4,113.03B | 9,681.19B | 11,322.48B | 15,726.69B | 0.05B | 0.05B |
| Leverage & Solvency | |||||||
| Debt Ratio | 0.05 | 0.00B | 0.00B | 0.00B | 0.00B | 0.35 | 0.37 |
| Valuation | |||||||
| Price to BookP/B | 2.14 | 7.61 | 22.90 | 14.75 | 4.19 | 2.98 | 0.52 |
| Enterprise Value | 0.04B | -9768.66B | -17201.77B | -18883.56B | -19980.80B | 0.06B | -0.01B |
| Market Capitalization | 0.05B | 0.18B | 0.60B | 0.42B | 0.12B | 0.09B | 0.02B |